Cannabis
CENTR Launches in Leading National Wine Superstore
Vancouver, British Columbia–(Newsfile Corp. – January 31, 2022) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the “Company”), one of North America’s leading functional beverage companies, today announced it has launched its sparkling CBD beverages in Total Wine & More’s Texas and Arizona stores, two of the Company’s key markets. CENTR’s sparkling, low calorie CBD beverages, including both CENTR and CENTR Sugar Free, are now sold in 29 Total Wine & More locations in these strategic markets.
Founded in 1991, Total Wine & More is the largest independent retailer of fine wine in the United States. Total Wine & More sells wine, beer, spirits and other beverages in 229 stores across 27 states and continues to grow.
“CENTR is proud to partner with Total Wine & More and make CENTR and CENTR Sugar Free available to millions of Texas and Arizonans via their family of stores,” said CENTR CEO Joseph Meehan. “Today’s announcement is just the latest illustration of the ongoing expansion of availability of CENTR’s sparkling beverages across America – we look forward to our partnership with Total Wine & More and to continuing to roll out CENTR’s family of sparking beverages across their entire growing platform.”
Consumers that do not yet have a local CENTR Brands retailer can visit CENTR’s online store to buy all our products, including the newly released CENTR Instant at: www.findyourcentr.com/shop.
About CENTR Brands Corp.
CENTR Brands Corp. is one of North America’s leading functional beverage companies. CENTR develops and markets non-alcoholic, functional ingestibles for the global market. The Company produces CENTR and CENTR Sugar Free, both sparkling, low calorie, CBD beverages as well as CENTR Instant, a family of on-the-go CBD powders. For more information visit www.findyourcentr.com, and follow on Instagram at @findyourcentr.
For further information, contact [email protected].
On behalf of the Board,
CENTR BRANDS CORP.
/s/Joseph Meehan
Joseph Meehan, Chief Executive Officer
This press release may contain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Actual results may differ from those indicated as a result of finalization of the Company’s financial statements as well as other risks and uncertainties. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/112115
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis3 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE4 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Humboldt3 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace